Sector portfolio · VC firm · United States

Casdin Capital's Biotech portfolio

Casdin Capital has backed 53 Biotech startups in rounds we track, $8.2B between them, shown by the stage each has reached. The best-funded is Blueprint Medicines.

53startups backed
4stages
$8.2Braised between them
Series Bbiggest stage

Casdin Capital's whole portfolioCasdin Capital's profile

Series B

21

Stage not reported

11

Series C and later

11

Series A

10

Segment by segment

Series B

21 startups · $2.8B raised

  1. Editas MedicineEditas Medicine is a clinical-stage genome editing company that develops genomic medicines for serious diseases.United States$335M
  2. Fulcrum TherapeuticsFulcrum Therapeutics is a biotechnology company that focuses on identifying and treating rare genetic diseases at their root cause.United States$310M
  3. CTCity TherapeuticsUnited States$235M
  4. Voyager TherapeuticsVoyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.United States$205M
  5. BBBolt BiotherapeuticsBolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.United States$189M
  6. Generation BioGeneration Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.United States$176M
  7. Neon TherapeuticsNEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.United States$161M
  8. Tenaya TherapeuticsTenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.United States$152M

Stage not reported

11 startups · $891M raised

  1. 4D Molecular Therapeutics4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.United States$307M
  2. Leyden LabsLeyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions foNetherlands$221M
  3. Vanqua BioVanqua Bio is a biopharmaceutical company based in Chicago, founded in 2019.United States$130M
  4. Contineum TherapeuticsContineum Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.United States$99M
  5. Remix TherapeuticsRemix Therapeutics is a biotechnology company that is working on developing small molecule medicines.United States$60M
  6. Gritstone bioGritstone bio is a biotechnology company that develops immunotherapies for cancer and infectious diseases.United States$33M
  7. Notch TherapeuticsNotch Therapeutics is an early-stage biotechnology company based in Vancouver, Canada, focused on immune cell therapy.Canada$16M
  8. Xcell BiosciencesXcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.United States$14M

Series C and later

11 startups · $3.9B raised

  1. Blueprint MedicinesBlueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines.United States$1.4B
  2. Relay TherapeuticsRelay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.United States$932M
  3. 23andMeUnited States$729M
  4. Magenta TherapeuticsMagenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.United States$187M
  5. 908 Devices908devices manufactures battery-operated, hand-held chemical detection tools used in mass spectrometry.United States$168M
  6. Genome MedicalGenome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.United States$98M
  7. CerevanceCerevance is a private, clinical-stage biopharmaceutical company based in Boston, Massachusetts, founded in 2016.United States$89M
  8. BDBlack Diamon TherapeuticsUnited States$85M

Series A

10 startups · $544M raised

  1. Codiak BiosciencesCodiak is a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics.United States$100M
  2. Mnemo TherapeuticsMnemo Therapeutics is a biotechnology company based in Paris, founded in 2019.France$90M
  3. Faze MedicinesFaze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$81M
  4. Exai BioExai Bio is a biotechnology company based in Palo Alto, California, founded in 2021.United States$68M
  5. CelsiusCelsius Network is a decentralized financial services platform founded in 2017, focused on bridging traditional finance and blockcUnited States$65M
  6. A2 BiotherapeuticsA2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.United States$57M
  7. DepixusDepixus is a life-science technology company based in Paris, France, specializing in magnetic force spectroscopy (MFS) to analyze France$35M
  8. Apton BiosystemsApton Biosystems develops an optical system designed for sequencing and protein detection.-$25M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Casdin Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapCasdin Capital portfolio map71 startups · $11BCo-investorsWho invests with Casdin Capital59 co-investorsSector portfolioTechstars' AI portfolio336 startups · $4.9BSector portfolioAlumni Ventures' AI portfolio302 startups · $36BSector portfolioAndreessen Horowitz's AI portfolio259 startups · $426BSector portfolioGeneral Catalyst's AI portfolio226 startups · $179B

Raising from investors like Casdin Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps